ACR 2006 Video

Tuesday, November 14, 2006
	Decrease in Need for Home Help with improved clinical status in RA Patients – Tracy Li, PhD, Bristol-Myers Squibb
	Predictors of Five-year Incident Fractures: Results From The National Osteoporosis Risk Assessment Program (NORA) – Ethel S. Siris, MD, Columbia University
	Efficacy of Traditional Chinese Acupuncture in the Treatment of Rheumatoid Arthritis (RA): A Double-Blind Controlled Pilot Study - again, ways to help symptoms without medication – Lai-Shan Tam, MD, Chinese University of Hong Kong
	A Six-month, Double-blind, Placebo-controlled, Durability of Effect Study of Pregabalin for Pain Associated With Fibromyalgia – Leslie J. Crofford, MD, University of Kentucky
	High Humidity and High Temperature Increase the Risk of Recurrent Gout Attacks: The Online Case-crossover Gout Study – Yuqing Zhang, DSc, Boston University
	Serum Matrix Metalloproteinase 3 is an Independent Predictor of Structural Damage Progression in Patients with Ankylosing Spondylitis – Walter P. Maksymowych, MD, University of Alberta
	The Association of New Cases of Cancer with Biologic Therapy – Frederick Wolfe, MD, National Data Bank for Rheumatic Diseases
	The Response To TNF-alpha Blockade In Rheumatoid Arthritis Is In Part Dependent On TNF-alpha Expression In The Synovium – Paul P. Tak, MD, Academic Medical Center/University of Amsterdam
	Abilities to Develop Protective Antibodies to Pneumococcal and Influenza Vaccine Are Maintained in RA Patients Treated with Adalimumab (Humira) – (Kivitz) speaking on behalf of Jeffrey Kaine, MD, Sarasota Arthritis Center
	National Study of Medical Complications in SLE Pregnancies – Megan E. Clowse, MD, MPH, Duke University Medical Center

Monday, November 13, 2006
	Quadriceps Strength and Its Relation to Cartilage Loss in Knee Osteoarthritis– Shreyasee Amin, Mayo Clinic
	Evidence for Reciprocal Relationships Among Pain, Weight Loss and Long Term Weight Maintenance for Obese Persons with Knee OA – Steffany Haaz, Johns Hopkins University
	Interim Report of a Randomized Double Blind Controlled Trial of Intra-articular Botulinum Toxin Type A (IA-BoNT/A) vs Placebo for Moderate and Severe Refractory Knee Pain due to Osteoarthritis – Maren Mahowald, MD, Minneapolis VA Medical Center
	The Lifetime Risk of Symptomatic Hip OA is One in Four – Louise Murphy, PhD, Centers for Disease Control and Prevention
	Autologous Non-myeloablative Peripheral Blood Stem Cell Transplantation in Patients with Systemic Sclerosis -shows there is hope for this disease – Walter G. Barr, MD, Northwestern University
	Evidence for a Window of Opportunity in a Double-blind Randomized Clinical Trial in Patients with Undifferentiated Arthritis: The Probable Rheumatoid Arthritis: Methotrexate Versus Placebo Treatment (the Prompt) study – Tom W.J. Huizinga, MD, Leiden University Medical Center
	Long-Term Efficacy and Safety of Adalimumab in Children with Juvenile Rheumatoid Arthritis: 48-Week Results – Daniel J. Lovell, MD, MPH, Children’s Hospital Medical Center
	Remission Induction in Early RA with Initial Infliximab and Methotrexate Therapy: The Disease Course After IFX Discontinuation in the BeSt Trial – CF Allaart, MD, Leiden University Medical Center, Leiden, The Netherlands
	Rapid Improvement of Signs and Symptoms Associated with Systemic 286 Juvenile Idiopathic Arthritis by Interleukin-6 Blockade- Results from a tocilizumab sJIA Phase III clinical trial and Efficacy and Safety of tocilizumab, an Anti-IL-6 Receptor Monoclonal Antibody, in Patients with Polyarticular or Oligoarticular Onset Juvenile Idiopathic Arthritis – Shumpei Yokota, MD, Department of Pediatrics, Yokohama City University School of Medicine

The videos require the Flash player to view, download and install the Flash Player.

• ACR 2006 News